Elevated expression of DDB2 has been linked to enhanced DNA repair capacity and poor clinical responses to DNA alkylating or interstrand cross-link agents in melanoma 11, glioblastoma 12, lung 13, and breast cancers 14. This evidence concerns the gene DDB2 and melanoma.